Netherlands
# |
Name |
Revenue |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 20.05 B
|
Dec. 31, 2023 | USD 24.98 | -2.69% |
|
Netherlands |
|
2 |
USD 4.90 B
|
Dec. 31, 2023 | USD 139.49 | 1.47% |
|
Netherlands |
|
3 |
USD 1.99 B
|
Dec. 31, 2023 | USD 121.51 | 5.06% |
|
Netherlands |
|
4 |
USD 1.97 B
|
Dec. 31, 2023 | USD 45.57 | -0.94% |
|
Netherlands |
|
5 |
USD 1.23 B
|
Dec. 31, 2023 | USD 673.61 | 1.66% |
|
Netherlands |
|
6 |
USD 245.32 M
|
Dec. 31, 2023 | USD 9.93 | 5.98% |
|
Netherlands |
|
7 |
USD 43.95 M
|
Dec. 31, 2023 | USD 39.01 | -3.56% |
|
Netherlands |
|
8 |
USD 15.84 M
|
Dec. 31, 2023 | USD 13.23 | -4.06% |
|
Netherlands |
|
9 |
USD 12.76 M
|
Dec. 31, 2023 | USD 23.67 | -3.70% |
|
Netherlands |
|
10 |
USD 7.19 M
|
Dec. 31, 2023 | USD 2.26 | -0.44% |
|
Netherlands |
|
11 |
USD 6.77 M
|
Dec. 31, 2023 | USD 0.98 | -1.01% |
|
Netherlands |
|
12 |
USD 0.00
|
Dec. 31, 2023 | USD 16.00 | -2.50% |
|
Netherlands |
The Pharmaceuticals company in Netherlands with the highest Revenue is Koninklijke Philips N.V. (Amsterdam Stock Exchange: PHIA.AS) at USD 20.05 B.
The Pharmaceuticals company in Netherlands with the lowest Revenue is Pharvaris N.V. (NasdaqGS: PHVS) at USD 0.00.
The top 10 Pharmaceuticals companies in Netherlands by Revenue are Koninklijke Philips N.V., IMCD N.V., Redcare Pharmacy NV, Qiagen N.V., argenx SE, Pharming Group N.V., Merus N.V., uniQure N.V., NewAmsterdam Pharma Company N.V. and ProQR Therapeutics N.V..
The bottom 10 Pharmaceuticals companies in Netherlands by Revenue are Pharvaris N.V., LAVA Therapeutics N.V., ProQR Therapeutics N.V., NewAmsterdam Pharma Company N.V., uniQure N.V., Merus N.V., Pharming Group N.V., argenx SE, Qiagen N.V. and Redcare Pharmacy NV.